Key takeaway: On August 17, 2026, Max Healthcare Institute Limited submitted an investor presentation in connection with its participation in the Motilal Oswal 22nd Annual Global Investor Conference. The presentation outlined the company's current capacity of over 6,100 beds across 21 facilities, emphasizing its position as India's second-largest hospital chain by revenue and EBITDA. Management highlighted key growth drivers, including a focus on expanding bed capacity through brownfield and greenfield projects, optimizing existing infrastructure, and leveraging technology. Financial highlights indicated a 15% year-over-year growth in gross revenue for Q1 FY27, with an operating EBITDA margin of 24.9%. The document also detailed the company's commitment to clinical excellence, research, and community service, alongside its strategic partnerships and digital initiatives. The presentation concluded with a focus on future growth potential and the importance of maintaining high standards in patient care.

Key takeaway: Max Healthcare Institute Limited held its earnings conference call on May 22, 2026, to discuss financial results for Q4 and FY 2026. Management reported a 10% year-on-year revenue growth, with operating EBITDA increasing by 8%. They highlighted the phased commissioning of over 20% additional brownfield capacity across several hospitals and the acquisition of a controlling stake in Kalinga Hospital Limited, marking their entry into Eastern India. The company plans to invest INR 1,400 crore in a new 700-bed hospital in Lucknow. Key performance metrics included an average occupancy rate of over 75%, a 10% increase in gross revenue to INR 2,664 crore, and a profit after tax of INR 387 crore. Management noted a decline in oncology revenue share due to the discontinuation of certain chemotherapy drugs, while digital revenue accounted for 31% of overall revenue. The call concluded with management expressing confidence in ongoing expansion and operational efficiency.

Key takeaway: On May 26, 2026, Max Healthcare Institute Limited submitted an investor presentation in connection with the UBS Asian Investment Conference 2026. The presentation outlined the company's current capacity of over 6,000 beds and highlighted its position as India's second-largest hospital chain by revenue and EBITDA. Management reported a market capitalization of ₹1.0 lakh crore and a 36% CAGR in market cap from April 2021 to May 2026. The document detailed the company's vision to be a well-regarded healthcare provider, emphasizing clinical excellence and patient care. Key growth drivers included brownfield and greenfield expansions, strategic partnerships, and a focus on digital healthcare solutions. Financial highlights for FY26 included a 16% increase in net revenue to ₹10,065 crore and a profit after tax of ₹1,631 crore, reflecting a 22% year-on-year growth. The presentation also covered the company's commitment to ESG initiatives and community health programs.

Key takeaway: On February 20, 2026, Max Healthcare Institute Limited submitted an investor presentation for the upcoming Kotak Chasing Growth Conference scheduled for February 23, 2026. The presentation outlined the company's current capacity of over 5,200 beds across 20 healthcare facilities, emphasizing its position as India's largest hospital chain by market capitalization. Management highlighted key growth drivers, including a focus on expanding bed capacity through brownfield and greenfield projects, enhancing operational efficiencies, and leveraging technology. Financial highlights indicated a revenue growth of 19% year-over-year for 9M FY26, with a reported profit after tax of ₹1,244 crore, reflecting a 30% increase from the previous year. The presentation also detailed the company's commitment to clinical excellence, research, and community service, alongside its strategic partnerships and digital initiatives aimed at improving patient care and operational performance. The document concluded with a note on the company's governance and sustainability efforts.

Key takeaway: Max Healthcare Institute Limited reported its Q3 and nine-month financial results for FY '26 during the earnings conference call held on February 6, 2026. Management noted that the Network achieved its 21st consecutive quarter of year-on-year growth, with revenue increasing by 10% and operating EBITDA growing by 4%. Despite challenges such as seasonal softness and disruptions in cashless services, overall occupancy rates remained strong. The company commissioned new brownfield beds, with significant occupancy already achieved. Management highlighted plans for geographic expansion, including a new 450-bed hospital in Pune by 2030. The call also addressed the impact of changes in CGHS pricing guidelines and the discontinuation of certain chemotherapy drugs on revenue. Free cash flow generation was reported at INR 281 crore, with ongoing capacity expansion projects funded by cash flows. The Network's gross revenue for the nine months reached INR 7,874 crore, reflecting a 19% year-on-year growth.

Key takeaway: On February 7, 2026, Max Healthcare Institute Limited submitted an investor presentation detailing its participation in upcoming investor conferences scheduled for February 9 and February 23, 2026. The presentation outlined the company's market position as India's largest hospital chain by market capitalization and its commitment to clinical excellence and patient care. Key highlights included a current capacity of over 5,200 beds, a revenue CAGR of 24% over four years, and a focus on expanding bed capacity through brownfield and greenfield projects. The document also emphasized the company's strategic partnerships, research initiatives, and strong financial performance, including a reported EBITDA margin of 25.3% for 9M FY26. Additionally, the presentation addressed the company's commitment to corporate social responsibility and environmental sustainability.